Zentalis Pharmaceuticals Inc is a key player in the global biopharmaceutical arena, dedicated to bringing transformative medicines to patients with the aid of ground-breaking oncology research and clinical capabilities. The company primarily operates across the US.
Zentalis operates within the healthcare sector, offering a spectrum of patient-centric solutions with a core emphasis on cancer diagnosis, treatment and preventive care. It has invested significantly in research and development endeavours to pioneer impactful innovations within the healthcare domain.
Stay up to date on the share price of ZNTL by adding it to your eToro watchlist.